GlassScriptPhysician profile
Kathryn Alleva
NPI 1437688983
$6,001.17
in general payments reported to CMS, 2019-2025
29 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $2,361 · 2021: $478 · 2022: $201 · 2023: $406 · 2024: $1,222 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558 · Long Term Medical Supply Or Device Loan: $1,186 · Travel and Lodging: $4.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.55 |
| Long Term Medical Supply Or Device Loan | $1,186.19 |
| Travel and Lodging | $4.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $1,892.00 | 2020 | |
| Integra Lifesciences Corporation | $1,400.29 | 2021-2025 | Acell, Integra, Amnioexcel |
| Stryker Corporation | $815.49 | 2019-2025 | Prostep Mica, Ortholoc 2 Lapifuse, Easyfuse |
| Organogenesis INC. | $334.12 | 2020-2023 | Puraply |
| Depuy Synthes Sales INC. | $183.00 | 2020-2025 | Motoband, Dynaforce |
| Medtronic, INC. | $157.75 | 2022-2025 | Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $153.41 | 2020-2024 | Nuzyra |
| Paragon 28, INC. | $151.65 | 2020-2025 | Portfolio, Precision Mis Bunion, Hammertube |
| Smith+Nephew, INC. | $128.95 | 2020-2025 | Grafix Pl, Collagenase Santyl, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Ani Pharmaceuticals, INC. | $96.80 | 2023-2025 | Purified Cortrophin Gel |
| Bioventus LLC | $83.30 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $71.61 | 2023-2025 | Qutenza |
| Orthofix Medical, INC. | $69.75 | 2022-2025 | Physio-Stim |
| Djo, LLC | $61.38 | 2021-2025 | Cmf |
| Arthrosurface Incorporated | $50.41 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $45.74 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Horizon Therapeutics Plc | $40.53 | 2021 | |
| Treace Medical Concepts, INC. | $36.05 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $33.01 | 2025 | |
| Solventum Corporation | $28.53 | 2025 | Prevena |
| Convatec INC. | $22.78 | 2025 | |
| Medela LLC | $21.49 | 2020 | |
| Amgen INC. | $19.69 | 2024 | Krystexxa |
| Grt US Holding, INC. | $19.22 | 2022 | |
| Polynovo North America LLC | $18.71 | 2024 | Novosorb Btm |
| Boston Scientific Corporation | $18.68 | 2024 | Wavewriter Alpha Prime 16 |
| Reprise Biomedical, INC. | $17.36 | 2025 | Miro3d |
| Ibsa Pharma INC. | $14.82 | 2023 | Tirosint, Licart |
| Heron Therapeutics, INC. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Alleva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.